Prevalence of the G20210A mutation of the prothrombin gene in Poland;Wystȩpowanie mutacji G20210A genu protrombiny w Polsce

Polskie Archiwum Medycyny Wewnetrznej

Volumn 104, Issue 5, 2000, Pages 729-733

  Bykowska, Ksenia ^a   Vertun Baranowska, Barbara ^a   Windyga, Jerzy ^a   Łopaciuk, Stanislaw ^a  

^a Instytutu Hematologii i T

Author keywords

20210A variant; Factor V Leiden; Prothrombin gene; Thrombophilia; Venous thrombosis

Indexed keywords

PROTHROMBIN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; COMORBIDITY; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; MUTATION; POLAND; POPULATION GENETICS; PREVALENCE; RECURRENT DISEASE; RISK; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA;

ADULT; AGED; CASE-CONTROL STUDIES; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETICS, POPULATION; HUMANS; MALE; MIDDLE AGED; MUTATION; ODDS RATIO; POLAND; PREVALENCE; PROTHROMBIN; RECURRENCE; RISK FACTORS; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 0034329347     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Poort S.R., Rosendaal F.R., Reitsma P.H., Bertina R.M.: A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 1996, 88, 3698.
2. Franco R.F., Santos S.E.B., Elion J. i wsp.: Prevalence of the G20210A polymorphism in the 3'-untranslated region of the prothrombin gene in different human populations. Acta Haematol., 1997, 100, 9.
3. Rosendaal F.R., Doggen C.J.M., Zivelin A. i wsp.: Geographic distribution of the 20210G to A prothrombin variant. Thromb. Haemost., 1998, 79, 706.
4. Hessner M.J., Luhm R.A., Pearson S.L. i wsp.: Prevalence of prothrombin G20210A, factor G1619A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR. Thromb. Haemost., 1999, 81, 733.
5. Łopaciuk S.: Epidemiologia i kliniczne aspekty wrodzonej trombofilii. Acta Haemat. Pol., 1999, 30 (suppl. 1), 193.
6. Miller S.A., Dykes D.D., Polesky H.F.: A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acids Res., 1988, 16, 12, 5.
7. Bertina R.M., Koelman B.P.C., Koster T. i wsp.: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 1994, 369, 64.
8. Frosst P., Blom H.J., Milos R. i wsp.: A candidate genetic risk factor for vascular dissease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet., 1995, 10, 111.
9. Herrmann F.H., Koesling M., Schröder W. i wsp.: Prevalence of factor V Leiden mutation in various populations. Genet. Epidemiol., 1997, 14, 403.
10. Łopaciuk S., Bykowska K., Vertun-Baranowska B. i wsp.: Wystȩpowanie czynnika V Leiden wśród chorych na zakrzepicȩ żylna̧ i kliniczna charakterystyka nosicieli tej mutacji. Acta Haemat. Pol., 1997, 28 (suppl. 3), 317 (streszczenie).
11. Tosetto A., Missiaglia E., Frezzato M., Rodeghiero F.: The VITA project: prothrombin G20210A mutation and venous thrombolism in the general population. Thromb. Haemost., 1999, 82, 1395.
12. Sacchi E., Duca F., Franceschi C. i wsp.: Prothrombin gene mutation (G20210A) in healthy centenarians. Thromb. Haemost., 1999, 81, 990.
13. Hillarp A., Zöller B., Swensson P.J., Dahlböck B.: The 20210A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb. Haemost., 1997, 78, 990.
14. Cumming A.M., Keeney S., Salden A. i wsp.: The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population. Brit. J. Haemat., 1997, 98, 353.
15. Souto J.C., Coll I., Llobet D. i wsp.: The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb. Haemost., 1998, 80, 366.
16. Zivelin A., Rosenberg N., Faier S. i wsp.: A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood, 1998, 92, 1119.
17. Akar N., Misirlioglu M, Akar E. i wsp.: Prothrombin gene 20210 G-A mutation in the Turkish population. Am. J. Hematol., 1998, 58, 249.
18. Cattaneo M., Chantarangkul V., Taioli E. i wsp.: The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels. Thromb. Res., 1999, 93, 1.
19. Leroyer C., Mercier B., Oger E. i wsp.: Prevalence of 20210A allele of the prothrombin gene in venous thromboembolism patients. Thromb. Haemost., 1998, 80, 49.
20. Horellou M.H., Aquilanti S., Canard J. i wsp.: The G20210A mutation in the prothrombin gene associated or not with another thrombophilia: a study in 143 propositi and 163 family members. Thromb. Haemost., 1999, (suppl., 180) (streszczenie).
21. Tosetto A., Rodeghiero F., Martinelli I. i wsp.: Additional genetic risk factors for venous thromboembolism in carriers of the factor V Leiden mutation. Brit. J. Haematol., 1998, 103, 876.
22. Alhenc-Gelas M., Le Cam-Duchez V., Emmerich J. i wsp.: The A20210 allele of the prothrombin gene is not frequently associated with the factor V Arg 506 to Gln mutation in thrombophilia families. Blood, 1997, 90, 1711.
23. Brown K., Luddington R., Williamson D. i wsp.: Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3'-untranslated region of the prothrombin gene. Brit. J. Haematol., 1997, 98, 907.
24. Eichinger S., Minar E., Hirschl M. i wsp.: The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene. Thromb. Haemost., 1999, 81, 14.
25. Lindmarker P., Schulman S., Sten-Linder M. i wsp.: The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in prothrombin gene. Thromb. Haemost., 1999, 81, 684.
26. Margaglione M., D'Andrea G., Colaizzo D. i wsp.: Coexistence of factor V Leiden and factor II A20210 mutations and recurrent venous thromboembolism. Thromb. Haemost., 1999, 82, 1583.